Funded Tech Companies
Corteria Pharmaceuticals
Headquartered in Paris, Corteria Pharmaceuticals raised its funding from OrbiMed, OMNES Capital and Jeito Capital.
Company Overview
Company Name
Corteria Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
128 rue de la Boétie
Paris, 75008
FR
Paris, 75008
FR
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as heart failure, sarcopenia and obesity subpopulations. Our strategy implies innovative patient stratification and target selection based on human evidence and a better understanding of the disease biology in patients. We are using cutting-edge methods to stratify the patients and identify those who will benefit the most from our treatments. Our focus is on worsening and acute heart failure, right heart failure, sarcopenia (including age-related sarcopenia and obesity-related sarcopenia) and obesity with established complications.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/7/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philip Janiak
Company Investors
- OrbiMed (Erez Chimovits)
- OMNES Capital
- Jeito Capital (Andreas Wallnoefer)
- V-Bio Ventures
- Kurma Partners
- Fountain Healthcare Partners
- Invivo Capital
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs